Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELUW) Return on Equity (2020 - 2025)

Historic Return on Equity for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to 3.54%.

  • Celularity's Return on Equity rose 50900.0% to 3.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.54%, marking a year-over-year increase of 50900.0%. This contributed to the annual value of 2.33% for FY2024, which is 6900.0% down from last year.
  • According to the latest figures from Q3 2025, Celularity's Return on Equity is 3.54%, which was up 50900.0% from 4.75% recorded in Q2 2025.
  • In the past 5 years, Celularity's Return on Equity ranged from a high of 4.75% in Q2 2025 and a low of 33.4% during Q1 2025
  • In the last 5 years, Celularity's Return on Equity had a median value of 0.86% in 2022 and averaged 2.54%.
  • Over the last 5 years, Celularity's Return on Equity had its largest YoY gain of 85700bps in 2025, and its largest YoY loss of -291300bps in 2025.
  • Quarter analysis of 5 years shows Celularity's Return on Equity stood at 1.02% in 2021, then surged by 108bps to 0.08% in 2022, then crashed by -7154bps to 5.51% in 2023, then increased by 20bps to 4.43% in 2024, then skyrocketed by 180bps to 3.54% in 2025.
  • Its Return on Equity was 3.54% in Q3 2025, compared to 4.75% in Q2 2025 and 33.4% in Q1 2025.